In last trading session, Enanta Pharmaceuticals Inc (NASDAQ:ENTA) saw 0.61 million shares changing hands with its beta currently measuring 0.58. Company’s recent per share price level of $8.03 trading at -$0.35 or -4.18% at ring of the bell on the day assigns it a market valuation of $171.30M. That closing price of ENTA’s stock is at a discount of -121.67% from its 52-week high price of $17.80 and is indicating a premium of 41.34% from its 52-week low price of $4.71.
For Enanta Pharmaceuticals Inc (ENTA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.29. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) trade information
Upright in the red during last session for losing -4.18%, in the last five days ENTA remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $8.03 price level, adding 8.33% to its value on the day. Enanta Pharmaceuticals Inc’s shares saw a change of 39.65% in year-to-date performance and have moved 7.07% in past 5-day. Enanta Pharmaceuticals Inc (NASDAQ:ENTA) showed a performance of 55.02% in past 30-days.
Wall Street analysts have assigned a consensus price target of 56 to the stock, which implies a rise of 85.66% to its current value. Analysts have been projecting 54 as a low price target for the stock while placing it at a high target of 87. It follows that stock’s current price would drop -572.48% in reaching the projected high whereas dropping to the targeted low would mean a loss of -572.48% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 21.82% while estimates for its earnings growth in next 5 years are of 12.54%.
Enanta Pharmaceuticals Inc (NASDAQ:ENTA)’s Major holders
FARALLON CAPITAL MANAGEMENT LLC is the top institutional holder at ENTA for having 2.1 million shares of worth $27.17 million. And as of 2024-06-30, it was holding 9.8914 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.93 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.1331 of outstanding shares, having a total worth of $25.09 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 629.6 shares of worth $5.06 million or 2.95% of the total outstanding shares. The later fund manager was in possession of 568.65 shares on Nov 30, 2024 , making its stake of worth around $4.57 million in the company or a holder of 2.67% of company’s stock.
